Exosomes derived from MSC as drug system in osteoarthritis therapy

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by irreversible cartilage damage.
• Mesenchymal stem cells (MSCs) show therapeutic potential for OA, but direct injection faces cost and ethical challenges.
• Exosomes derived from MSCs (MSC-Exos) are key mediators of MSCs' therapeutic effects, carrying bioactive substances.

Purpose of the Study:

• To review the therapeutic mechanisms of MSC-Exos in osteoarthritis treatment.
• To summarize the current research on MSC-Exo preparation methods.
• To explore the application of MSC-Exos as drug delivery systems for OA.

Main Methods:

• Literature review of studies on MSC-Exos for osteoarthritis.
• Analysis of MSC-Exo composition and biological functions.
• Evaluation of MSC-Exo preparation techniques and drug delivery applications.

Main Results:

• MSC-Exos contain diverse bioactive molecules (nucleic acids, proteins, lipids, microRNAs).
• MSC-Exos exhibit therapeutic potential by modulating immunity, inhibiting apoptosis, and promoting regeneration in OA.
• MSC-Exos serve as effective targeted delivery systems for OA therapy.

Conclusions:

• MSC-Exos represent a viable cell-free therapeutic strategy for osteoarthritis.
• Further research into MSC-Exo preparation and drug delivery is crucial for clinical translation.
• MSC-Exos hold significant promise for advancing osteoarthritis regenerative medicine.